The New Federal Blueprint to Lower Drug Prices

    View Author May 2018

    On Friday, May 11, 2018, President Trump vowed to fix “the injustice of high drug prices” by announcing the “Blueprint to Lower Drug Prices” (the Blueprint) to address the following challenges:

    1. Excessively high drug prices
    2. Seniors and government programs overpaying for drugs
    3. High out-of-pocket costs for consumers
    4. Lack of transparency in drug pricing
    5. Free-riding by foreign nations as to US investment in innovation

    This piece provides analysis of the Blueprint and its proposed reforms.